|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-8-26
|
|
pubmed:abstractText |
Mood disorders and other neuropsychiatric disorders are common adverse events limiting tolerability of alpha-interferon (IFN) therapy for hepatitis C virus (HCV). Because efavirenz (EFV) frequently produces neuropsychiatric side effects, we studied the effect of EFV in the incidence of these side effects in HIV/HCV patients receiving IFN.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
61-3
|
|
pubmed:meshHeading |
pubmed-meshheading:18667933-Anti-HIV Agents,
pubmed-meshheading:18667933-Anxiety Disorders,
pubmed-meshheading:18667933-Benzoxazines,
pubmed-meshheading:18667933-Depression,
pubmed-meshheading:18667933-Drug Therapy, Combination,
pubmed-meshheading:18667933-Female,
pubmed-meshheading:18667933-HIV Infections,
pubmed-meshheading:18667933-Hepatitis C, Chronic,
pubmed-meshheading:18667933-Humans,
pubmed-meshheading:18667933-Interferon-alpha,
pubmed-meshheading:18667933-Male,
pubmed-meshheading:18667933-Mental Disorders,
pubmed-meshheading:18667933-Mood Disorders
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.
|
|
pubmed:affiliation |
Infectious Diseases, Hospital Ramón y Cajal, Madrid, Spain. cqueredar.hrc@salud.madrid.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
